• 1
    Stacey D, DeGrasse C, Johnston L. Addressing the support needs of women at high risk for breast cancer: evidence-based care by advanced practice nurses. Oncology Nursing Forum, 2002; 29: E77–E84. Retrieved 12 August 2002 from
  • 2
    Fisher B, Joseph P, Costantino D et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Journal of the National Cancer Institute, 1998; 90: 13711388.
  • 3
    Powles T, Eeles R, Ashley S et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomized chemoprevention trial. Lancet, 1998; 352: 98101.
  • 4
    Veronesi V, Maisonneuve P, Costa A et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Lancet, 1998; 352: 9397.
  • 5
    Chlebowski RT, Collyar DE, Somerfield MR, Pfister DG. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies : Tamoxifen and Raloxifene. Journal of Clinical Oncology, 1999; 17: 19391955.
  • 6
    O'Connor AM, Fiset V, DeGrasse C et al. Decision aids for patients considering options affecting cancer outcomes: evidence or efficacy and policy implications. Journal of the National Cancer Institute Monographs, 1999; 25: 6780.
  • 7
    O'Connor AM, Stacey, D. Rovner, D et al. Decision aids for people facing health treatment or screening decisions. (Cochrane Review) In: The Cochrane Library, Issue 3. Oxford: Update Softwear, 2001.
  • 8
    O'Connor AM, Drake ER, Fiset V, Graham ID, Laupacis A, Tugwell P. The Ottawa patient decision aids. Effective Clinical Practice, 1999; 2: 163170.
  • 9
    National Cancer Institute of Canada. Canadian Cancer Statistics 2002. Toronto: National Cancer Institute, 2002.
  • 10
    National Cancer Institute. Probability of breast cancer in American women. In: National Cancer Institute. 7 May 2001. (23 May 2002).
  • 11
    National Cancer Institute. National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial (BCPT). In: National Cancer Institute. 4 June 1998. s/PressInfo/PressKit/press/slides/1.html (4 June 1998).
  • 12
    National Cancer Institute. Breast Cancer Risk Assessment Tool. Bethesda, MD: National Cancer Institute, 2000.
  • 13
    Stacey D, O'Connor A. Cochrane Inventory of Existing Patient Decision Aids. Ottawa Health Research Institute. 30 August 2002. (18 October 2002).
  • 14
    Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes and Control, 1994; 5: 7382.
  • 15
    Trentheim-Dietz A, Newcomb PA, Storer BE et al. Body size and risk of breast cancer. American Journal of Epidemiology, 1997; 145: 10111019.
  • 16
    American Institute for Cancer Research. Food, Nutrition, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 1997.
  • 17
    Friedenreich CM, Thune I, Brinton LA et al. Epidemiologic issues related to the association between physical activity and breast cancer. Cancer Supplement, 1998; 83: 600610.
  • 18
    Cline JM, Hughes CL. Phytochemicals for the prevention of breast and endometrial cancer. Cancer Treatment and Research, 1998; 94: 107134.
  • 19
    Boyd NF, Greenberg C, Lockwood G et al. Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: Results from a randomized trial. Journal of the National Cancer Institute, 1997; 89: 488496.
  • 20
    Boyd NF, Martin LJ, Noffel M et al. A meta-analysis of studies of dietary fat and breast cancer risk. British Journal of Cancer, 1993; 68: 627636.
  • 21
    Holmes MD, Hunter DJ, Colditz GA et al. Association of dietary intake of fat and fatty acids with risk of breast cancer. Journal of the American Medical Association, 1999; 281: 914920.
  • 22
    Affenito SG, Kerstetter J. Position of the American Dietetic Association and dieticians of Canada: women's health and nutrition. Canadian Journal of Dietetic Practice and Research, 1999; 60: 85100.
  • 23
    Klijn JG, Janin N, Cortes-Funes H et al. Should prophylactic surgery be used in women at high risk of breast cancer? European Journal of Cancer, 1997; 33: 21492159.
  • 24
    Ontario Cancer Genetics Network. Ontario Cancer Genetics Network Consensus Recommendations for Breast Cancer Risk Management in Familial Breast/Ovarian Cancer. Toronto: Ontario Cancer Genetics Network, 1999.
  • 25
    O'Connor AM, Tugwell P, Wells GA et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Education and Counseling, 1998; 33: 267279.
  • 26
    Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? Social Science and Medicine, 1997; 44: 681692.
  • 27
    Entwistle VA, Sheldon TA, Sowden A, Watt IS. Evidence-Informed patient choice. International Journal of Technology Assessment in Health Care, 1998; 14: 2.
  • 28
    Hersey J, Matheson J, Lohr K. Consumer Health Informatics and Patient Decision-making (AHCPR Pub. No. 98-N001). Rockville, MD: Agency for Health Care Policy and Research, 1997.
  • 29
    Llewellyn-Thomas H. Presidential Address. Medical Decision Making, 1995; 15: 101106.
  • 30
    Mulley A. Outcomes research: implications for policy and practice. In Smith, DelamotherT (eds) Outcomes in Clinical Practice. London: BMJ Publishing Group, 1995.
  • 31
    Rothert M, Talarcyzk GJ. Patient compliance and the decision making process of clinicians and patients. Journal of Compliance in Health Care, 1987; 2: 5571.
  • 32
    Canadian Nurses Association. Advanced Nursing Practice: A National Framework. Ottawa, Ontario: Canadian Nurses Association, 2000.
  • 33
    Barry MJ, Fowler MJ, Mulley AG, Henderson JV, Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Medical Care, 1995; 33: 771782.
  • 34
    O'Connor AM. Validation of a Decisional Conflict Scale. Medical Decision Making, 1995; 15: 2530.
  • 35
    Drake E, Engler-Todd L, O'Connor AM et al. Development and evaluation of a decision aid about prenatal testing for women of advanced maternal age. Journal of Genetic Counseling, 1999; 8: 217233.
  • 36
    Fiset V, O'Connor AM, Evans WK et al. The development and evaluation of a decision aid for patients with stage IV non-small cell lung cancer. Health Expectations, 2000; 3: 125136.
  • 37
    Hing M, Laupacis A, O'Connor AM et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. Journal of the American Medical Association, 1999; 282: 737743.
  • 38
    O'Connor AM, Tugwell P, Wells GA et al. Randomized trial of a portable self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy. Medical Decision Making, 1998; 18: 295303.
  • 39
    O'Connor AM, Tugwell P, Wells G. Testing a portable, self-administered, decision aid for post-menopausal women considering long-term hormone replacement therapy (HRT) to prevent osteoporosis and heart disease. Medical Decision Making, 1994; 14: 438 (abstract).
  • 40
    Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosomatic Medicine, 1979; 41: 209218.
  • 41
    Lerman C, Schwartz MD, Miller SM, Daly M, Sands C, Rimer BK. A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style. Health Psychology, 1996; 15: 7583.
  • 42
    O'Connor AM. Evaluation Measures. In: Ottawa Health Research Institute. 6 September 2001. (23 May, 2002).
  • 43
    Cohen J. Statistical Power Analysis for the Behavioral Sciences. Toronto: Academic Press, 1977.
  • 44
    O'Connor AM, Jacobsen M, Elmslie T et al. Simple versus complex patient decision aids: is more necessarily better? Paper presented at the Annual Meeting of the International Society for Technology Assessment in Health Care, The Hague, Netherlands, June 2000.